Author

Hong Yan

h-index 3 View on Semantic Scholar

We have 3 of 18 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Unraveling the allosteric inhibition mechanism of TLR2 by CU-CPT22: A combined DFT and enhanced sampling MD study.

Aberrant activation of Toll-like receptors 1/2 (TLR1/2) is critically implicated in the pathogenesis of numerous inflammatory and immune-mediated disorders, positioning this receptor complex as a high-value therapeutic target. CU-CPT22, a well-established small-molecule TLR1/2 inhibitor, exhibits potent and selective i...

Peng Jiao, Cheng-Liang Ni, Hao Jin et al. · Journal of Molecular Graphic... · 0 citations

Sep 2026

Identification of FLT3-ITD inhibitors through AI-guided virtual screening, biochemical validation, DFT analysis, and molecular dynamics simulation.

An AI-assisted discovery workflow integrating graph neural network (GNN) modeling, virtual screening, biochemical validation, and mechanistic analysis to identify novel FLT3-ITD inhibitors demonstrates that combining AI-based prioritization with structure-based screening enables efficient discovery of structurally dive...

Cong Wang, Hui-Jie Han, Xiao-Kun Zhang et al. · Bioorganic chemistry (Print) · 0 citations

Aug 2026

Dual targeting of VEGFR2 and ErbB3 by a novel quinoline derivative E5: Mechanistic insights from DFT, molecular docking and MD simulations.

A novel quinoline derivative, 7-(benzyloxy)-N-(3-chloro-2-fluorophenyl)-6-methoxyquinolin-4-amine (E5), was successfully identified as a potent dual-target inhibitor with favourable dual-target binding potency, highlighting E5 as a promising lead compound that warrants further investigation to address clinical anti-ang...

Xin-Yu Zhou, Ya-Nan Yuan, Chao-Chun Wei et al. · Computational biology and ch... · 0 citations